LexDanaLexDanabeta
Inventor

Jeremy Green

Inventor
Waltham, MA, US

Overview

55→
Patents
2000–2019
Patent span
Human necessities
Primary field (CPC A)

Patents· 55 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

C07Dprimary
C07DHeterocyclic compounds33%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations32%
A61KPreparations for medical, dental or toiletry purposes20%
C07BGeneral methods of organic chemistry5%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium4%
C07KPeptides2%
C12NMicroorganisms or enzymes2%
G16BBioinformatics, i.e. information and communication technology [ict] specially adapted for genetic or protein-related data processing in computational molecular biology2%
C07CAcyclic or carbocyclic compounds1%
PatentTitleYear
10,501,439DNA-PK inhibitors201910,442,791DNA-PK inhibitors201910,391,095DNA-PK inhibitors201910,301,304Selective inhibitor of phosphatidylinositol 3-kinase-gamma201910,076,521DNA-PK inhibitors20189,925,188'DNA-PK inhibitors and uses thereof'20189,878,993'DNA-PK inhibitors for treatment of cancer'20189,592,232'DNA-PK inhibitors'20179,376,448'DNA-PK inhibitors'20169,296,701'DNA-PK inhibitors'20168,987,454'Azaindoles useful as inhibitors of JAK and other protein kinases'20158,921,376'Pyrrolopyridines useful as inhibitors of protein kinase'20148,735,593'Aminopyridines useful as inhibitors of protein kinases'20148,722,889'Azaindoles useful as inhibitors of JAK and other protein kinases'20148,664,219'Aminopyrimidines useful as inhibitors of protein kinases'20148,653,088'Compositions useful as inhibitors of protein kinases'20148,598,361'Process for preparing 5-fluoro-1H-pyrazolo [3,4-B] pyridin-3-amine and derivatives therof'20138,501,446'Azaindoles useful as inhibitors of JAK and other protein kinases'20138,410,133'Aminopyridines useful as inhibitors of protein kinases'20138,288,400'Compositions useful as inhibitors of protein kinases'20128,278,306'C-met protein kinase inhibitors'20128,268,818'Inhibitors of C-MET and uses thereof'20128,242,272'Process for preparing 5-fluoro-1H-pyrazolo [3,4-B] pyridin-3-amine and derivatives thereof'20128,188,281'Azaindoles useful as inhibitors of JAK and other protein kinases'20128,058,271'Selective inhibitors of rock protein kinase and uses thereof'20118,017,619'Compositions useful as inhibitors of protein kinases'20117,883,881'Inhibitors of GSK-3 and crystal structures of GSK-3β protein and protein complexes'20117,700,609'Compositions useful as inhibitors of protein kinases'20107,666,647'Inhibitors of GSK-3 and crystal structures of GSK-3β protein and protein complexes'20107,612,065'Inhibitors of c-JUN N-terminal kinases (JNK)'20097,601,718'Compositions useful as inhibitors of protein kinases'20097,547,794'Compositions useful as inhibitors of protein kinases'20097,531,556'Compositions useful as inhibitors of rock and other protein kinases'20097,514,448'Azaindoles useful as inhibitors of rock and other protein kinases'20097,507,826'Azaindoles useful as inhibitors of JAK and other protein kinases'20097,452,873'Inhibitors of GSK-3 and uses thereof'20087,390,808'Inhibitors of GSK-3 and crystal structures of GSK-3β protein and protein complexes'20087,304,071'Protein kinase inhibitors and uses thereof'20077,271,181'Inhibitors of p38'20077,268,136'Compositions useful as inhibitors of protein kinases'20077,253,187'Heterocyclic inhibitors of ERK2 and uses thereof'20077,169,798'Inhibitors of c-Jun N terminal kinases (JNK) and other protein kinases'20077,157,476'Aminofurazan compounds useful as protein kinase inhibitors'20077,084,159'Inhibitors of c-Jun N-terminal kinases (JNK) and other protein kinases'20067,056,944'Pyrazole compositions useful as inhibitors of erk'20066,916,798'Inhibitors of GSK-3 and uses thereof'20056,825,190'Protein kinase inhibitors and uses thereof'20046,743,791'Heterocyclic inhibitors of ERK2 and uses thereof'20046,699,865'Pyrazole compositions useful as inhibitors of ERK'20046,693,108'Inhibitors of c-JUN N terminal kinases (JNK) and other protein kinases'20046,653,300'Pyrazole compounds useful as protein kinase inhibitors'20036,642,227'Inhibitors of c-Jun N-terminal kinases (JNK) and other protein kinases'20036,593,357'Pyrazole compositions useful as inhibitors of ERK'20036,528,509'Pyrazole compositions useful as inhibitors of ERK'20036,093,742'Inhibitors of p38'2000

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2000–2019Patents assigned to VERTEX PHARMA (54)· patent assignee history
2000–2012Based in Burlington, MA, US· patent location history
2007Based in Burlinton, MA, US· patent location history
2009–2019Based in Waltham, MA, US· patent location history
2010Based in Burlngton, MA, US· patent location history
2011–2014Patents assigned to GREEN JEREMY (12)· patent assignee history
2011–2014Patents assigned to COME JON (4)· patent assignee history
2012–2014Patents assigned to GAO HUAI (4)· patent assignee history
2012–2014Patents assigned to JIMENEZ JUAN-MIGUEL (4)· patent assignee history
2013–2015Based in Rockville, MD, US· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
VERTEX PHARMA542000–2019
GREEN JEREMYself122011–2014
COME JON42011–2014
GAO HUAI42012–2014
JIMENEZ JUAN-MIGUEL42012–2014
Locations
LocationPatentsSpan
Waltham, Massachusetts, US252009–2019
Burlington, Massachusetts, US252000–2012
Rockville, Maryland, US32013–2015
Burlngton, Massachusetts, US12010
Burlinton, Massachusetts, US12007